Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
Sell
42
KNSL Quote, Financials, Valuation and Earnings
Last price:
$457.00
Seasonality move
:
10.01%
Day range:
$452.43 - $460.52
52-week range:
$355.12 - $536.84
Dividend yield:
0.14%
P/E ratio:
25.60x
P/S ratio:
6.69x
P/B ratio:
7.15x
Volume:
103.8K
Avg. volume:
209.1K
1-year change:
-9.98%
Market cap:
$10.6B
Revenue:
$1.6B
EPS (TTM):
$17.79
Analysts' Opinion
-
Consensus RatingKinsale Capital Group has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 9 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $474.11, Kinsale Capital Group has an estimated upside of 4.1% from its current price of $455.42.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $402.00 representing 100% downside risk from its current price of $455.42.
Fair Value
-
According to the consensus of 11 analysts, Kinsale Capital Group has 4.1% upside to fair value with a price target of $474.11 per share.
KNSL vs. S&P 500
-
Over the past 5 trading days, Kinsale Capital Group has overperformed the S&P 500 by 4.43% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Kinsale Capital Group does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Kinsale Capital Group has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Kinsale Capital Group reported revenues of $412.1M.
Earnings Growth
-
Kinsale Capital Group has grown year-over-year earnings for 9 quarters straight. In the most recent quarter Kinsale Capital Group reported earnings per share of $4.68.
Enterprise value:
8.9B
EV / Invested capital:
5.32x
Price / LTM sales:
6.69x
EV / EBIT:
16.89x
EV / Revenue:
5.58x
PEG ratio (5yr expected):
0.74x
EV / Free cash flow:
9.31x
Price / Operating cash flow:
11.16x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
9.51%
Net Income Margin (TTM):
26.13%
Return On Equity:
32.24%
Return On Invested Capital:
28.21%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $834.5M | $1.2B | $1.6B | $351.2M | $412.1M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $6.88 | $13.21 | $17.79 | $4.43 | $4.68 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.3B | $1.7B | $2.3B | $3.3B | $2.4B | |
| Total Assets | $1.5B | $2B | $2.7B | $3.8B | $4.9B | |
| Current Liabilities | $68.9M | $39.4M | $63.4M | $92.5M | $99.1M | |
| Total Liabilities | $970.7M | $1.3B | $2B | $2.7B | $3.4B | |
| Total Equity | $576.2M | $699.3M | $745.4M | $1.1B | $1.5B | |
| Total Debt | $42.6M | $42.7M | $195.7M | $183.8M | $184.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $557.8M | $859.8M | $976.3M | $211.5M | $213M | |
| Cash From Investing | -$708.6M | -$860.9M | -$960.1M | -$244.5M | -$198M | |
| Cash From Financing | $186M | -$28.5M | -$29.7M | -$3.2M | -$13.4M | |
| Free Cash Flow | $550.9M | $853.2M | $952.4M | $210.4M | $202.2M | |
KNSL
Sector
Market Cap
$10.6B
$618.6M
Price % of 52-Week High
84.83%
85.59%
Dividend Yield
0.14%
2.01%
Shareholder Yield
--
3.87%
1-Year Price Total Return
-9.98%
9.44%
Beta (5-Year)
1.249
0.715
Dividend yield:
0.14%
Annualized payout:
$0.60
Payout ratio:
3.36%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$443.75
200-day SMA
Buy
Level
$445.20
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$442.31
Relative Strength Index (RSI14)
Buy
Level
56.20
ADX Line
Neutral
Level
0
Williams %R
Sell
Level
-19.651
50-day SMA
Buy
Level
$445.28
MACD (12, 26)
Sell
Level
-1.64
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Neutral
Level
--
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.5172)
Sell
CA Score
(Annual)
Level (-0.708)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-0.1217)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.
Stock Forecast FAQ
In the current month, KNSL has received 2 Buy ratings 9 Hold ratings, and 0 Sell ratings. The KNSL average analyst price target in the past 3 months is $474.11.
-
Where Will Kinsale Capital Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that Kinsale Capital Group share price will rise to $474.11 per share over the next 12 months.
-
What Do Analysts Say About Kinsale Capital Group?
Analysts are divided on their view about Kinsale Capital Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kinsale Capital Group is a Sell and believe this share price will drop from its current level to $402.00.
-
What Is Kinsale Capital Group's Price Target?
The price target for Kinsale Capital Group over the next 1-year time period is forecast to be $474.11 according to 11 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is KNSL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Kinsale Capital Group is a Hold. 9 of 11 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of KNSL?
You can purchase shares of Kinsale Capital Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kinsale Capital Group shares.
-
What Is The Kinsale Capital Group Share Price Today?
Kinsale Capital Group was last trading at $457.00 per share. This represents the most recent stock quote for Kinsale Capital Group. Yesterday, Kinsale Capital Group closed at $455.42 per share.
-
How To Buy Kinsale Capital Group Stock Online?
In order to purchase Kinsale Capital Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
49
SMTC alert for Mar 17
Semtech [SMTC] is down 0.49% over the past day.
Buy
62
PLPC alert for Mar 17
Preformed Line Products [PLPC] is up 3.8% over the past day.
Sell
50
NUTX alert for Mar 17
Nutex Health [NUTX] is up 4.82% over the past day.
